Cancer is a group of diseases characterized by uncontrolled cell growth. Rather than a single illness, it encompasses more than 100 distinct conditions that can arise in virtually any tissue in the body. What unites them all is a shared biological problem: cells that ignore the body’s normal signals to stop dividing, eventually forming masses called tumors or, in the case of blood cancers, flooding the bloodstream with abnormal cells.
How Normal Cells Become Cancerous
Your body contains trillions of cells that grow, divide, and die on a tightly controlled schedule. Cancer begins when mutations, or errors in a cell’s DNA, disrupt that schedule. These mutations typically accumulate over time rather than happening all at once. A single mutation rarely causes cancer on its own; the process usually involves changes in multiple genes that regulate the cell cycle, DNA repair, and a self-destruct mechanism called programmed cell death.
Two categories of genes play central roles. Tumor suppressor genes act as brakes, stopping a cell from dividing when something is wrong. When a gene like p53 is mutated, the cell loses the ability to pause and fix DNA damage, so it keeps dividing with errors intact. Proto-oncogenes are the accelerator. When genes like Ras or Myc mutate, they push cells to grow and divide faster than normal, overriding the body’s built-in checks. The combination of a stuck accelerator and broken brakes is what allows damaged cells to multiply unchecked.
Over time, these rogue cells acquire additional capabilities. They learn to build their own blood supply, dodge the immune system, resist signals telling them to die, and eventually invade surrounding tissues. These shared traits, sometimes called the hallmarks of cancer, are what make the disease so difficult to control once it progresses.
Benign vs. Malignant Tumors
Not every abnormal growth is cancer. Benign tumors are localized clumps of cells that don’t invade nearby tissue or spread to distant parts of the body. They can still cause problems if they press on vital structures (a benign brain tumor, for instance, can affect vision or speech), but they lack the defining feature of cancer: the ability to metastasize.
Malignant tumors are the ones classified as cancer. Their cells can break away from the original mass, travel through the bloodstream or the lymphatic system, and establish new growths in organs far from where they started. This process, called metastasis, is what makes cancer life-threatening. A breast tumor that stays in the breast is treatable with surgery in many cases. The same cancer, once it has seeded the lungs, liver, or bones, becomes far harder to manage.
How Cancer Spreads
Metastasis was once thought to be a passive process, with cancer cells simply falling into nearby blood or lymph vessels as the tumor grew. The picture is now understood to be more complex. Cancer cells actively exploit the body’s own transport systems. They hijack chemical signals called chemokines, which normally guide immune cells through the body, to find and enter lymphatic vessels and travel toward lymph nodes. They also use adhesion molecules, proteins that immune cells rely on to move between tissues and vessels, to latch onto vessel walls and gain entry.
Once inside the circulatory or lymphatic system, cancer cells can settle in a new organ, adapt to the local environment, and begin forming a secondary tumor. This is why cancer staging pays close attention to whether cells have reached the lymph nodes or spread to distant sites.
The Five Major Categories
Cancers are classified by the type of tissue where they originate. There are five broad categories:
- Carcinomas start in epithelial tissue, the cells lining your skin, organs, and glands. They account for 80 to 90 percent of all cancer cases and include lung, breast, colon, and prostate cancers.
- Sarcomas arise in connective and supportive tissues like bone, cartilage, muscle, fat, and tendons. They are relatively rare compared to carcinomas.
- Leukemias are cancers of the bone marrow, where blood cells are produced. They typically involve an overproduction of immature white blood cells and are sometimes called liquid or blood cancers because they don’t form solid tumors.
- Lymphomas develop in the lymphatic system, the network of nodes, vessels, and organs that produces infection-fighting white blood cells. Hodgkin and non-Hodgkin lymphoma are the two main subtypes.
- Myelomas originate in plasma cells within the bone marrow. Plasma cells normally produce antibodies, so myeloma disrupts the body’s ability to fight infection.
This classification matters because cancers from different tissue types behave differently and respond to different treatments. A sarcoma in the thigh and a carcinoma in the colon may both be called “stage III cancer,” but they are fundamentally different diseases at the cellular level.
What Causes It
Most cancer is not inherited. Only about 5 to 10 percent of all cancer diagnoses trace back to genetic mutations passed down from a parent. The remaining 90 to 95 percent result from mutations that a person acquires during their lifetime through a combination of aging, environmental exposures, and lifestyle factors. Every time a cell divides, there is a small chance of a copying error in its DNA. Over decades, these errors accumulate, which is why cancer risk rises sharply with age.
Known risk factors that accelerate this process include tobacco use, ultraviolet radiation from the sun, certain viral infections (like HPV and hepatitis B), exposure to industrial chemicals, obesity, and heavy alcohol consumption. In some cases, no clear external cause can be identified. The mutation is simply the result of biological randomness during normal cell division.
How Cancer Is Staged
When cancer is diagnosed, doctors assign a stage to describe how far it has progressed. The most widely used framework is the TNM system, which evaluates three factors:
- T (Tumor): The size of the primary tumor and how deeply it has grown into surrounding tissue. T1 is small and localized; T4 means the tumor is large or has invaded nearby structures.
- N (Nodes): Whether cancer cells have reached nearby lymph nodes. N0 means no lymph node involvement; higher numbers (N1, N2, N3) indicate more nodes affected.
- M (Metastasis): Whether the cancer has spread to distant parts of the body. M0 means it has not; M1 means it has.
These three values are combined to assign an overall stage, typically ranging from stage I (early, localized) to stage IV (spread to distant organs). Staging guides treatment decisions and gives a general picture of prognosis, though outcomes vary widely depending on the specific cancer type, its location, and the individual patient’s health.
The Global Burden
Cancer is one of the leading causes of death worldwide. In 2022, there were an estimated 20 million new cases and 9.7 million deaths globally, according to the World Health Organization. The three most common cancers that year were lung cancer (2.5 million new cases, or 12.4 percent of the total), female breast cancer (2.3 million cases, 11.6 percent), and colorectal cancer (1.9 million cases, 9.6 percent). These numbers continue to climb as the global population ages and grows, making cancer not just a medical challenge but a major public health priority in every country on earth.